Brief: Verve Therapeutics Reports Clearance Of Clinical Trial Authorisation Application By UK Health Regulator For Verve-101
21/09/2022 11:50
Sept 21 (Reuters) - Verve Therapeutics Inc VERV.O :
* VERVE THERAPEUTICS ANNOUNCES CLEARANCE OF CLINICAL TRIAL
AUTHORISATION APPLICATION BY THE UNITED KINGDOM MEDICINES AND
HEALTHCARE PRODUCTS REGULATORY AGENCY FOR VERVE-101 IN PATIENTS
WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
* VERVE THERAPEUTICS ANNOUNCES CLEARANCE OF CLINICAL TRIAL
AUTHORISATION APPLICATION BY THE UNITED KINGDOM MEDICINES AND
HEALTHCARE PRODUCTS REGULATORY AGENCY FOR VERVE-101 IN PATIENTS
WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Source text for Eikon: ID:nGNX1L4F9Q
Further company coverage: VERV.O
((Reuters.Briefs@thomsonreuters.com;))